Visualisation of significantly differentially expressed genes (DEGs). by Mohammed A. Alfattah (18271622)

Top 10 most significant DEGs. by Foluwasomi A. Oyefeso (15999113)

Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR. by Jordan A. Gunning (18143970)

Database of the significantly enriched gene ontology terms of the DEGs. by Camilo Escobar-Sierra (18150360)

The profile of the 263 significant differentially expressed metabolites (DEMs). by Haiying Yang (11707725)

Subjects:

DEG KEGG pathway. by Xinzhuan Yao (10095316)

Gene set enrichment analysis with identified DEG (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s compared to unstimulated ILC2s (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance). by Christina Gress (11536883)

“…<p>Gene set enrichment analysis with identified DEG (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s compared to unstimulated ILC2s (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).…”

Significantly activated/inactivated canonical pathways in the DEGs induced by iso-α-acids intake. by Takahito Takase (10104912)

Significantly enriched GO terms found in the upregulated DEGs induced by iso-α-acids intake. by Takahito Takase (10104912)

Significantly enriched GO terms found in the downregulated DEGs induced by iso-α-acids intake. by Takahito Takase (10104912)

Significantly Enriched Pathways. by Jiyong Zhang (2498740)

Subjects:

Late onset DEG (identified at later timepoints) from significant pathways. by Sung-Hyun Park (196247)

Sampling point (Source: by Yonggang Huang (223155)

Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs. by Wenbin Wu (292223)

Summary of top five significant pathways enriched by the 345 late onset DEG. by Sung-Hyun Park (196247)

After moderate and severe TBI, PWI revealed CBF was significantly decreased in the ipsilateral cortex and hippocampus at several time points relative to sham animals. by Juliana Sanchez-Molano (16792787)

Insufficient disulfide bond formation results in a decrease in alkaline phosphatase activity and accumulation of the reduced form of DegP in LCFA-utilizing cells. by Kanchan Jaswal (9542107)

“…<i>(E) The reduced form of DegP accumulates significantly in oleate-grown cells</i>. WT BW25113 was grown either in TBK-Brij or TBK-Ole, and cultures were harvested at time points T1, T2, and T3 (indicated in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009081#pgen.1009081.g001" target="_blank">Fig 1B</a>). …”

Differentially expressed genes (DEGs) exhibiting both increased and decreased expression levels. by Liwen Wang (276995)

Gene set enrichment analysis with identified DEGs (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s pre-incubated with the selective DP₂ antagonist fevipiprant compared to metabolite activated ILC2s without fevipiprant stimulation (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance). by Christina Gress (11536883)

“…<p>Gene set enrichment analysis with identified DEGs (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s pre-incubated with the selective DP₂ antagonist fevipiprant compared to metabolite activated ILC2s without fevipiprant stimulation (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).…”

Proportion of individuals’ general benefits scores that increased, decreased, or remained unchanged between time points. by Jessie B. Moore (12578140)